Prospects of N-Acetylcysteine and Melatonin as Treatments for Tramadol-Induced Renal Toxicity in Albino Rats

Tramadol (TD) has played an important role in the treatment of pain. However, renal toxicity due to TD abuse is a serious clinical challenge. This study assessed the effects of n-acetylcysteine (NAC) and melatonin (MT) on TD-induced renal toxicity in albino rats.
Rats were randomized into groups and treated with MT (10mg/kg/day), NAC (10mg/kg/day) and TD (15, 30, and 45mg/kg/day) respectively. Rats were pretreated with MT (10mg/kg/day) and NAC (10mg/kg/day) prior to treatment with TD (15, 30, and 45mg/kg/day) intraperitonialy for 7days respectively. Rats were sacrificed, serum extracted and evaluated for creatinine, urea and uric acid. The kidneys were evaluated for malondialdehyde (MDA), superoxide dismutase (SOD), catalase, (CAT), and glutathione (GSH) levels.
Treatment with MT and NAC did not produce significant (P>0.05) effects on serum creatinine, urea, uric acid and kidney MDA, SOD, CAT, and GSH levels when compare to saline control. In contrast, serum creatinine, urea, uric acid and kidney MDA levels were increased while kidney SOD, CAT, and GSH levels were decreased significantly (P The present study showed prospects of n-acetylcysteine and melatonin as remedies for tramadol associated renal toxicity.